MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma
Abstract Osteosarcoma is the most prevalent primary bone malignancy in children and young adults. Resistance to chemotherapy remains a key challenge for effective treatment of patients with osteosarcoma. The aim of the present study was to investigate the preventive role of metallothionein-2A (MT2A)...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2019
|
| Subjects: | |
| Online Access: | https://doaj.org/article/22d185a0684f4e9a8d8e736977224818 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|